Novadel Pharma Inc. (fka NVDL)

[Schris]

This same report was advertised at Yahoo for $138.00.

Here (see below) you can get it for 10 British Pounds.

(A Link to SUDA's Annual Reports for Free is at the bottom of this message)

Analyst Research Report Snapshot
title:

Suda Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
price:

£10.00
provider:

Reuters Investment Profile
date:

08 Feb 2014
pages:

12
type:

AcrobatPDF
companies referenced:

SUD.AX
Available for Immediate Download
summary:

This report is essential reading for any serious investor, providing comprehensive financial information on a company's performance, position and cash flows over the past 3 years, including interim data. This information, extracted from reported financial statements, forms the building blocks for any analysis undertaken by investment professionals. - Key Stats and Ratios including; Valuation Ratios (e.g. Price/Earnings), Per Share Data (e.g. EPS), Profitability Ratios (e.g. Gross Margin), Management Effectiveness (e.g. Return on Equity), Financial Strength (e.g. Quick Ratio) and Dividend Information (e.g. Dividend Yield). - 3 years of history are available for most ratios (see above). - Share performance data and 12 month chart - Profit & Loss Account (3 years) - Balance sheet (3 years) - Cash Flow Statement (3 years) - Educational content: Definitions of ratios and guidance on using the data - Graphical analysis: All the key data in the report is charted. Reuters Investment Profile reports are now available for over 25,000 companies globally.Every report is updated weekly to ensure that the information remains current.

Link to SUDA's Annual Reports for Free:

http://www.sudaltd.com.au/index.php/annual-reports